Could Cell Therapy Target the Symptoms of Severe Covid-19?
The excessive inflammatory response seen in the most serious cases of Covid-19, along with shortages…
25/05/2020 - 5 minutes
Cell therapy
Pluristem Scores €50M From EIB to Develop Covid-19 Cell Therapy
Israeli cell therapy biotech Pluristem Therapeutics has secured up to €50M in non-dilutive funding from…
29/04/2020 - 3 minutes
UK Startup to Manufacture Cell and Gene Therapies with Microfluidics
The UK company MicrofluidX has closed a €1.6M (£1.4 M) seed funding round to develop…
24/04/2020 - 3 minutes
Mogrify Teams Up With Sangamo To Streamline Cell Immunotherapies
The UK cell conversion startup Mogrify and the US genomic medicine company Sangamo have reached…
23/04/2020 - 3 minutes
Irish Biotech Raises €18M to Develop Non-Viral Cell Therapy Technology
The Irish company Avectas has closed a Series C round to develop cell therapies that…
16/04/2020 - 2 minutes
This Startup Is Automating the Manufacture of Gene and Cell Therapies
In London, the firm Ori Biotech is developing an automated way to manufacture gene and…
28/02/2020 - 3 minutes
Sponsored
by Bio-Techne
Tackling the Challenges in Cell and Gene Therapy Manufacturing
The excitement about cell and gene therapies is almost tangible within the biotech and pharma…
24/02/2020 - 7 minutes
Sponsored
by Anemocyte
How Can We Tackle the Bottleneck in Plasmid Production for Gene Therapies?
The cell and gene therapy sector is booming. At the end of 2019, there were…
03/02/2020 - 5 minutes
Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas
The UK biotech Adaptimmune Therapeutics has inked a deal worth up to €806M with Japanese…
15/01/2020 - 2 minutes
What Makes a Successful Biotech?
How does it feel to have co-developed the most successful drug in the world? This…
11/12/2019 - 12 minutes
Mass Layoffs as Dutch Biotech Cancels Phase III Cell Therapy Trial
The Dutch company Kiadis Pharma has discontinued the development of a cell therapy in blood…
13/11/2019 - 2 minutes
UK Biotech Launched to Target ‘Dark Antigens’ with Cancer Vaccines
The London-based startup Ervaxx has launched with a €15.8M Series A round to develop cancer…
06/11/2019 - 2 minutes
